U.S. Markets closed

Cerulean Pharma Inc. (CERU)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.4012+0.02 (+4.94%)
At close: 4:00PM EDT
People also watch
  • IGXT (MC $50 M) NDA filing for MEGA thin-flim Cialis (better than Viagra) this month =10++ BAGGER Potential ! PLEASE read this guys and then join us to make big money .A LIFETIME OPPORTUNITY HERE GUYS !!!

    2 US-NDA submission within 2 months ,lot of Cash and heavily underpriced at a valuation of just $50 million .1 Big drug partnered with Endo Pharma already under review by FDA market launch expected in 1H 2018 .GL

    Intelgenx (IGXT)

    MarketCap $50 Million
    Cash ~$12 Million (including convertible debt) =cash untill 2021+
    Price: 0.80

    NDA submission for tadalafil (erectile dysfunction) thin-film version of Blockbuster drug Cialis in June or July
    NDA resubmission for Rizaport (migraine) in early Q3
    Partnership for Tadalafil in 2H 2017


    IntelGenx previously confirmed the bioequivalence of Tadalafil to Eli Lilly’s Cialis, which had sales of $1.5-billion in 2016 but faces generic competition in 2020. IntelGenx has an exclusive license for oral films from Lilly for its dosing patent, which would allow Tadalafil to enter the ED market in the U.S. free from patent litigation from Lilly. Dr. Matzen explains that Tadalafil, which offers a discrete dosing alternative, could enter the market in 2018, with up to three years of market exclusivity before Cialis is hit with generic competition.

    Tadalafil is an erectile dysfunction (ED) treatment that boasts bioequivalence with Cialis, the current leading brand, and with a successful biostudy in-hand a 505(b)(2) NDA is set to be filed any day now, meaning that a full launch should be expected in mid-2018. Cialis is already winning-out over Viagra in terms of numbers of prescriptions, which is largely down to price and efficacy, but when Tadalafil comes to market with the same product in a more convenient and discreet delivery mechanism, IntelGenX should see a massive number of customers take-up its services.

    IntelGenx has multi-faceted BD approach for its oral films
    With a burgeoning pipeline of pharmaceutical oral films, IntelGenx’s (OTCQX:IGXT; TSXV:IGX) business development strategy is focused on partnering its product pipeline along with actively meeting with potential partners to explore manufacturing
  • guys hold on to this stock and play today #DCTH
  • (Tops) is next to spike
  • See ya, going over to AVEO
  • Way to hold longs!!!
  • Sweet, made $600 today.
  • Is it time to make a move on CERU? I started receiving notifications from AWEsome_STOCKS the other week and so far they have presented interesting new trade ideas.
  • About a month ago, posted that ceru worth less than a dollar....
  • CERU, bouncing back to $2-$3 soon.
  • Most likely when DARE takes over they'll institute a 10:1 or 15:1 if not more for reverse slip. I foresee the decline of Mirena and hormonal birth control, so I'm in long haul!
  • What are development going on here?
  • Is this the time or wait for .60?
  • CERU, looks to be overvalued at this price Do you guys find it difficult to know when to buy or sell something? I prefer to get my stocks from awe-someSTOCKS.
  • look like strong rebound imminent
  • Does anyone know what happens to these shares? I'm holding like 13k shares and am under water.
    Are they going to be converted to shares in Dare? Or are they eventually going to 0 and should I sell now to cut my losses?
  • Does anyone have any idea what's happening right now??!!
  • This POS just keeps on being a POS. Investigate this scam of a company!
  • Now, CERU, this Scam is pumped to Dump from $0.3.
  • So this is just a stock that will hang on until they think everyone will cash out?? I am not about to cash out for 63 cents a share. I hope this CEO end up in jail and becomes someones special friend.
  • dead